article thumbnail

Being a BASICS Doctor

Mind The Bleep

Since I started responding in 2017, I have been first on scene at an anaphylaxis where the ambulance arrived 45 minutes after me, as well as a medical cardiac arrest at the side of a rural road where my assistants were a relative and a delivery driver.

article thumbnail

Diagnostics: Blood Transfusion Reactions

Taming the SRU

Mild Reactions Transfusion Reaction Frequency Timeline Presentation Management Allergic - 1-3% with platelet and plasma components - 0.1-0.3% Adverse reactions to transfusion of blood products and Best Practices for Prevention.” Critical Care Nursing Clinics of North America , vol. 271–290, [link] Garraud, O.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

SGEM#188: Icatibant Bites the Dust – For ACE-I Induced Angioedema

The Skeptics' Guide to EM

[display_podcast] Date: September 12th, 2017 Reference: Sinert et al. J Allergy Clin Immunol Pract 2017. display_podcast] Date: September 12th, 2017 Reference: Sinert et al. J Allergy Clin Immunol Pract 2017. Though this disorder is routinely treated with medications for anaphylaxis (i.e. Reference: Sinert et al.

article thumbnail

52 in 52 – #36: Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus

EMDocs

population at large Enrollment was terminated at an interim analysis due to predefined futility criteria that suggested that there was a 1% chance that carrying the trial to completion would demonstrate a most effect or least effective treatment.

article thumbnail

Annals of B Pod: Anti-Xa Overdose

Taming the SRU

The patient is agitated on a backboard with C-collar in place. J Thromb Haemost. Jan; 8(1): 202-4. Samuelson, B.T., Laboratory assessment of the anticoagulant activity of direct oral anticoagulants: a systematic review. Jan; 151(1): 127-138. Cuker A, et al. J Am Coll Cardiol. Sep 16; 64(11): 1128-39.

article thumbnail

Review of the ATHOS 3 trial

Northwestern EM Blog

The ATHOS-3 trial in 2017 explored the efficacy of angiotensin II as a vasopressor for severe vasodilatory shock. The study was designed as a phase III multicenter randomized placebo control trial taking place across 75 intensive care units in the United States from 2015 to 2017.

Shock 52
article thumbnail

Fearsome Foliage - An Overview of Toxic Plants

Taming the SRU

Anaphylaxis, hypoglycemia, cardiotoxicity, and neurotoxicity can all be seen following exposure to poisonous plants. 2017 Sep-Dec;21(3):101-104. Thankfully, some of the more common and/or dangerous plant poisonings have been well-categorized, and are summarized below. General Management Manage airway, breathing, and circulation.